Vera Therapeutics, Inc. - 10-Q Filing
Vera Therapeutics filed its quarterly report on Form 10-Q for the quarter ended March 31, 2026. The filing includes details about a $50 million milestone under an agreement with Ares Trading SA tied to achieving specified worldwide aggregate annual net sales of $500 million.
Tickers: $VERA